Skip to content

Clinical study on acupoint thread embedding combined with Yanghe Tongluo Drink in the treatment of overweight and obese non-puerperal mastitis

Clinical study on acupoint thread embedding combined with Yanghe Tongluo Drink in the treatment of overweight and obese non-puerperal mastitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076333
Enrollment
Unknown
Registered
2023-10-04
Start date
2022-01-17
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-puerperal mastitis

Interventions

Intervention group:Acupoint thread embedding+Yanghe Tongluo Drink
Control group:Yanghe Tongluo Drink

Sponsors

Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria of non-puerperal mastitis. Pathology shows acute and chronic inflammation, ductal dilatation, plasma cell infiltration, and granuloma formation. A breast histopathological examination has been completed within 3 months before enrollment; (2) Female, aged = 18 and = 65, non puerperal; (3) Body mass index BMI = 24; (4) Understand and agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Pregnant women; (2) Combined with breast cancer and other malignant diseases; (3) Patients who had undergone quadrant mastectomy for non-puerperal mastitis before treatment; (4) It is complicated with autoimmune diseases, serious diseases of the heart, brain, kidney, and other organs, infectious diseases, and mental and behavioral abnormalities, which are not convenient for observation; (5) Have participated in other clinical studies or are participating in other clinical studies within 3 months before enrollment; (6) Inability to swallow traditional Chinese medicine or diseases that significantly affect gastrointestinal function, such as malabsorption syndrome, total gastrectomy or small bowel resection, weight loss surgery, inflammatory bowel disease, or incomplete or complete intestinal obstruction; (7) Patients who are allergic to catgut embedding or have ulceration, injury, or infectious skin diseases; (8) Other conditions or diseases that the researcher believes may bring obvious risks to the patient or confuse the research results and should be excluded.

Design outcomes

Primary

MeasureTime frame
Effective rate;

Secondary

MeasureTime frame
Cure rate;Weight;Waistline;Abdominal circumference;Hipline;Body Mass Index (BMI);Waist-Hip Ratio;Classification and determination table of TCM physique;Inflammatory factor;Lipid metabolism;Self-Rating Anxiety Scale (SAS);Hamilton Anxiety Scale (HAMA);Recurrence rate;New occurrence rate;Healing time;

Countries

China

Contacts

Public ContactJi Yajie

Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

2373602874@qq.com+86 133 0177 9329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026